About Us

V-Nano aims to become the European leader as contract development and manufacturing organization (CDMO) for precision therapies. V-Nano manages the complete development of a wide range of active pharmaceutical ingredients (API):

  • Cytotoxic or high potency API
  • Conventional API
  • Large molecules
  • Small molecules

to be vectorized in a sterile process for parenteral formulations. The core of V-Nano business revolves around complete manufacturing and formulation approaches for specialty and orphan drug pharmaceutical companies through an entirely new model leveraging, among other things:

State-of-the-art dedicated nanotechnology platform

Cutting edge fill and finish line

Dedicated pilot-scale laboratory for scale-up

High performing and experienced formulation and characterization department


V-nano CDMO is supported by the Occitanie Region